State Street Corp Has $305.91 Million Position in West Pharmaceutical Services Inc. (NYSE:WST)

Share on StockTwits

State Street Corp lowered its holdings in West Pharmaceutical Services Inc. (NYSE:WST) by 4.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,157,046 shares of the medical instruments supplier’s stock after selling 103,991 shares during the quarter. State Street Corp owned about 2.92% of West Pharmaceutical Services worth $305,912,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Price T Rowe Associates Inc. MD boosted its holdings in West Pharmaceutical Services by 1.5% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 8,900,778 shares of the medical instruments supplier’s stock worth $1,113,932,000 after acquiring an additional 130,672 shares during the last quarter. BlackRock Inc. boosted its holdings in West Pharmaceutical Services by 1.5% during the 2nd quarter. BlackRock Inc. now owns 7,216,285 shares of the medical instruments supplier’s stock worth $903,119,000 after acquiring an additional 104,494 shares during the last quarter. WCM Investment Management LLC boosted its holdings in West Pharmaceutical Services by 4.7% during the 3rd quarter. WCM Investment Management LLC now owns 1,353,495 shares of the medical instruments supplier’s stock worth $191,953,000 after acquiring an additional 61,308 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in West Pharmaceutical Services by 0.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 829,183 shares of the medical instruments supplier’s stock worth $103,771,000 after acquiring an additional 5,471 shares during the last quarter. Finally, Invesco Ltd. boosted its holdings in West Pharmaceutical Services by 66.9% during the 2nd quarter. Invesco Ltd. now owns 597,787 shares of the medical instruments supplier’s stock worth $74,812,000 after acquiring an additional 239,545 shares during the last quarter. 90.21% of the stock is owned by institutional investors and hedge funds.

WST has been the topic of a number of analyst reports. Zacks Investment Research raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $160.00 price objective on the stock in a report on Sunday, November 3rd. ValuEngine downgraded shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $131.39.

WST opened at $149.43 on Tuesday. The company has a debt-to-equity ratio of 0.17, a current ratio of 3.00 and a quick ratio of 2.31. The company has a market capitalization of $10.88 billion, a price-to-earnings ratio of 53.18, a P/E/G ratio of 3.34 and a beta of 1.24. The firm’s fifty day moving average price is $145.39 and its two-hundred day moving average price is $135.43. West Pharmaceutical Services Inc. has a 1 year low of $91.75 and a 1 year high of $152.10.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, October 24th. The medical instruments supplier reported $0.79 EPS for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.08. The company had revenue of $456.10 million for the quarter, compared to analysts’ expectations of $450.03 million. West Pharmaceutical Services had a return on equity of 16.66% and a net margin of 12.82%. The business’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.76 EPS. As a group, equities analysts anticipate that West Pharmaceutical Services Inc. will post 3.14 EPS for the current year.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Featured Article: What is the Beige Book?

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.